US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Neurocrine Biosciences

156.22

-0.3500-0.22%

Post-market: 156.220.00000.00%17:00 EDT

Volume:890.85K

Turnover:139.70M

Market Cap:15.93B

PE:22.90

High:159.67

Open:157.20

Low:156.12

Close:156.57

52wk High:186.12

52wk Low:122.14

Shares:102.00M

Float Shares:100.00M

Volume Ratio:1.00

T/O Rate:0.89%

Dividend:- -

Dividend Rate:- -

EPS(TTM):6.82

EPS(LYR):4.67

ROE:22.09%

ROA:11.70%

PB:4.31

PE(LYR):33.45

Loading ...

Overview Company News Filings

Stock Track | Neurocrine Biosciences Soars 8.85% After-Hours on Strong Q1 Earnings Beat and $2.9B Acquisition

Neurocrine Biosciences Q1 adjusted EPS beats estimates, sales up 44%

Neurocrine reports Q1 adjusted EPS $1.94, consensus $1.70

Neurocrine backs FY26 Ingrezza net product sales $2.7B-$2.8B

Neurocrine Q1 FY26 net income rises to $197.9 million; net product sales climb 44% to $811 million

BRIEF-Neurocrine Biosciences Q1 Adjusted EPS USD 1.94 Vs. IBES Estimate USD 1.15

Neurocrine Biosciences Q1 Net Income USD 197.9 Million

THOMSON REUTERS

Neurocrine Biosciences Inc - Reaffirms 2026 Full-Year Ingrezza Net Sales Guidance $2.7-$2.8 Bln

THOMSON REUTERS

Neurocrine Biosciences executives to present at Bank of America Health Care Conference

BRIEF-Neurocrine Biosciences Announces New Survey Results Showing Significant Burden Of Tardive Dyskinesia On Employment

Neurocrine Biosciences Announces New Survey Results Showing Significant Burden of Tardive Dyskinesia on Employment

THOMSON REUTERS

Neurocrine Biosciences Announces Initiation Of Phase 1 Clinical Study Evaluating Nbip-'2118, A Corticotropin-Releasing Factor Type 2 Receptor Agonist

Neurocrine initiates Phase 1 study of NBIP-‘2118

Neurocrine initiates Phase 1 trial of obesity drug candidate NBIP-2118

Neurocrine Biosciences Inc - Initial Data From Phase 1 Nbip-'2118 Study Expected in 2027

THOMSON REUTERS

Neurocrine presents two-year Crenessity data

Neurocrine says Phase 3 pediatric CAH trial shows durable hormone control at two years

Neurocrine Biosciences Presents New Two-Year Crenessity® (Crinecerfont) Data Demonstrating Durable Hormone Control, Reduced Glucocorticoid Exposure and Meaningful Clinical Improvements in Pediatric Patients With Classic Congenital Adrenal Hyperplasia

THOMSON REUTERS

Earning Preview: Neurocrine Biosciences revenue expected to increase by 37.63%, institutions are bullish

A Look At Neurocrine Biosciences (NBIX) Valuation After CRENESSITY Phase 3 CAHtalyst Adult Results

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/NBIX/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"NBIX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NBIX\",,,,,undefined,":{"symbol":"NBIX","market":"US","secType":"STK","nameCN":"Neurocrine Biosciences","latestPrice":156.22,"timestamp":1789156800000,"preClose":156.57,"halted":0,"volume":890853,"hourTrading":{"tag":"盘后","latestPrice":156.22,"preClose":156.22,"latestTime":"17:00 EDT","volume":42614,"amount":6657162.48912,"timestamp":1789160434146,"change":0,"changeRate":0,"amplitude":0.015107},"delay":0,"changeRate":-0.0022354218560387963,"floatShares":99995570,"shares":102000000,"eps":6.823004,"marketStatus":"Post-Mkt","change":-0.35,"latestTime":"09-11 18:31:13 EDT","open":157.195,"high":159.67,"low":156.12,"amount":139695523.05741,"amplitude":0.022674,"askPrice":159,"askSize":1,"bidPrice":156,"bidSize":20,"shortable":3,"etf":0,"ttmEps":6.823004,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789171200000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":832824000000,"exchange":"NASDAQ","adjPreClose":156.57,"preHourTrading":{"tag":"盘前","latestPrice":157.95,"preClose":156.57,"latestTime":"09:29 EDT","volume":4238,"amount":665436.3508,"timestamp":1789133399990,"change":1.38,"changeRate":0.008814,"amplitude":0.044892},"postHourTrading":{"tag":"盘后","latestPrice":156.22,"preClose":156.22,"latestTime":"17:00 EDT","volume":42614,"amount":6657162.48912,"timestamp":1789160434146,"change":0,"changeRate":0,"amplitude":0.015107},"volumeRatio":0.999037,"impliedVol":0.2339,"impliedVolPercentile":0.0199},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NBIX\",,,,,undefined,":{"symbol":"NBIX","floatShares":99995570,"roa":"11.70%","roe":"22.09%","lyrEps":4.67,"volumeRatio":0.999037,"shares":102000000,"dividePrice":0,"high":159.67,"amplitude":0.022674,"preClose":156.57,"low":156.12,"week52Low":122.1375,"pbRate":"4.31","psRate":"4.72","week52High":186.12,"institutionHeld":0.95,"latestPrice":156.22,"committee":0.904762,"eps":6.823004,"divideRate":0,"volume":890853,"delay":0,"ttmEps":6.823004,"open":157.195,"prevYearClose":141.83,"prevWeekClose":155.64,"prevMonthClose":154.03,"prevQuarterClose":168.535,"fiveDayClose":158.35,"twentyDayClose":150.82,"sixtyDayClose":156.42},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NBIX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-30","symbol":"NBIX","fiscalQuarterEnding":"2026/06","expectedEps":1.88,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785384000000,"reportTimeType":"post","actualEps":2.36},{"market":"US","date":"2026-05-05","symbol":"NBIX","fiscalQuarterEnding":"2026/03","expectedEps":1.28,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1777953600000,"reportTimeType":"post","actualEps":1.41},{"market":"US","date":"2026-02-11","symbol":"NBIX","fiscalQuarterEnding":"2025/12","expectedEps":1.78,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1770786000000,"reportTimeType":"post","actualEps":1.43},{"market":"US","date":"2025-10-28","symbol":"NBIX","fiscalQuarterEnding":"2025/09","expectedEps":1.58,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1761624000000,"reportTimeType":"post","actualEps":2.04},{"market":"US","date":"2025-07-30","symbol":"NBIX","fiscalQuarterEnding":"2025/06","expectedEps":0.98,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1753848000000,"reportTimeType":"post","actualEps":1.06}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NBIX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NBIX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.4667,"hold":0.1333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4667,"analysts":30,"updateTime":1780459200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NBIX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NBIX","date":"2026-09-10","current":22.896073,"percent":0.06759,"low":15.452095,"twenty":27.727905,"median":40.453654,"eighty":110.387029,"high":905.986584,"avg":99.899992,"sd":176.09884,"marketCap":15769853940},"quantilePoints":[{"date":"2021-09-17","current":25.043543,"twenty":-57.122936,"median":21.874823,"eighty":264.839255,"marketCap":9133380205},{"date":"2021-09-24","current":24.65167,"twenty":-56.515676,"median":21.983228,"eighty":264.839255,"marketCap":8990464100},{"date":"2021-10-01","current":26.330755,"twenty":-56.073302,"median":22.061434,"eighty":264.839255,"marketCap":9602826483},{"date":"2021-10-08","current":27.010694,"twenty":-54.272284,"median":22.130844,"eighty":264.839255,"marketCap":9850800122},{"date":"2021-10-15","current":27.130073,"twenty":-53.483205,"median":22.199493,"eighty":264.839255,"marketCap":9894337478},{"date":"2021-10-22","current":26.870554,"twenty":-53.14751,"median":22.365311,"eighty":264.839255,"marketCap":9799691051},{"date":"2021-10-29","current":27.355854,"twenty":-53.059611,"median":22.416552,"eighty":264.839255,"marketCap":9976679870},{"date":"2021-11-05","current":19.879776,"twenty":-52.91578,"median":22.430689,"eighty":264.839255,"marketCap":8842524454},{"date":"2021-11-12","current":18.76859,"twenty":-52.59512,"median":22.430689,"eighty":264.839255,"marketCap":8348268984},{"date":"2021-11-19","current":18.346297,"twenty":-52.419753,"median":22.430689,"eighty":264.839255,"marketCap":8160432931},{"date":"2021-11-26","current":18.551045,"twenty":-52.090504,"median":22.430689,"eighty":264.839255,"marketCap":8251504957},{"date":"2021-12-03","current":16.994105,"twenty":-51.971325,"median":22.430689,"eighty":264.839255,"marketCap":7558978098},{"date":"2021-12-10","current":16.987707,"twenty":-51.971325,"median":22.430689,"eighty":264.839255,"marketCap":7556132097},{"date":"2021-12-17","current":18.476398,"twenty":-51.971325,"median":22.430689,"eighty":264.839255,"marketCap":8218301614},{"date":"2021-12-23","current":18.147947,"twenty":-51.971325,"median":22.430689,"eighty":264.839255,"marketCap":8072206907},{"date":"2021-12-31","current":18.16501,"twenty":-51.971325,"median":22.430689,"eighty":264.839255,"marketCap":8079796242},{"date":"2022-01-07","current":16.064207,"twenty":-51.955042,"median":22.42362,"eighty":264.609771,"marketCap":7145359316},{"date":"2022-01-14","current":16.712577,"twenty":-51.955042,"median":22.42362,"eighty":264.609771,"marketCap":7433754063},{"date":"2022-01-21","current":16.017286,"twenty":-51.955042,"median":22.42362,"eighty":264.609771,"marketCap":7124488644},{"date":"2022-01-28","current":16.364931,"twenty":-51.955042,"median":22.42362,"eighty":264.609771,"marketCap":7279121353},{"date":"2022-02-04","current":17.305493,"twenty":-51.955042,"median":22.42362,"eighty":264.609771,"marketCap":7697483470},{"date":"2022-02-11","current":90.557458,"twenty":-51.955042,"median":22.431842,"eighty":264.609771,"marketCap":8113948252},{"date":"2022-02-18","current":90.693144,"twenty":-51.955042,"median":22.522526,"eighty":264.609771,"marketCap":8126105713},{"date":"2022-02-25","current":94.45608,"twenty":-51.955042,"median":22.586516,"eighty":264.609771,"marketCap":8463264811},{"date":"2022-03-04","current":93.743886,"twenty":-51.955042,"median":22.661461,"eighty":264.609771,"marketCap":8399452213},{"date":"2022-03-11","current":94.91316,"twenty":-51.955042,"median":22.80063,"eighty":264.609771,"marketCap":8504219165},{"date":"2022-03-18","current":98.99499,"twenty":-51.908672,"median":22.903884,"eighty":264.609771,"marketCap":8869951067},{"date":"2022-03-25","current":99.622146,"twenty":-51.908672,"median":23.045631,"eighty":264.609771,"marketCap":8926144250},{"date":"2022-04-01","current":101.588652,"twenty":-51.908672,"median":23.1378,"eighty":264.609771,"marketCap":9102343214},{"date":"2022-04-08","current":106.372046,"twenty":-51.908672,"median":23.19199,"eighty":264.609771,"marketCap":9530935287},{"date":"2022-04-14","current":105.521665,"twenty":-51.879725,"median":23.286066,"eighty":264.609771,"marketCap":9454741141},{"date":"2022-04-22","current":99.794282,"twenty":-51.235376,"median":23.504791,"eighty":264.609771,"marketCap":8941567652},{"date":"2022-04-29","current":95.96752,"twenty":-50.869461,"median":23.733072,"eighty":264.609771,"marketCap":8598689764},{"date":"2022-05-06","current":106.411117,"twenty":-50.538701,"median":24.05378,"eighty":264.609771,"marketCap":7597753757},{"date":"2022-05-13","current":112.603765,"twenty":-50.513367,"median":24.270178,"eighty":264.609771,"marketCap":8039908807},{"date":"2022-05-20","current":115.361299,"twenty":-50.513367,"median":24.572517,"eighty":264.609771,"marketCap":8236796731},{"date":"2022-05-27","current":124.624471,"twenty":-50.513367,"median":24.659455,"eighty":264.609771,"marketCap":8898187232},{"date":"2022-06-03","current":127.890676,"twenty":-50.513367,"median":24.724335,"eighty":264.609771,"marketCap":9131394287},{"date":"2022-06-10","current":126.244188,"twenty":-50.513367,"median":24.885236,"eighty":264.609771,"marketCap":9013834993},{"date":"2022-06-17","current":124.865421,"twenty":-50.513367,"median":25.0449,"eighty":264.609771,"marketCap":8915391031},{"date":"2022-06-24","current":131.50492,"twenty":-50.518997,"median":25.258455,"eighty":264.839255,"marketCap":9389451274},{"date":"2022-07-01","current":132.856915,"twenty":-50.518997,"median":25.998572,"eighty":264.839255,"marketCap":9485983703},{"date":"2022-07-08","current":127.930835,"twenty":-50.518997,"median":26.276232,"eighty":264.839255,"marketCap":9134261587},{"date":"2022-07-15","current":127.395391,"twenty":-50.518997,"median":26.439753,"eighty":264.839255,"marketCap":9096030922},{"date":"2022-07-22","current":127.556024,"twenty":-50.518997,"median":26.634392,"eighty":264.839255,"marketCap":9107500121},{"date":"2022-07-29","current":126.003238,"twenty":-50.518997,"median":26.826436,"eighty":264.839255,"marketCap":8996631194},{"date":"2022-08-05","current":815.065239,"twenty":-50.518997,"median":26.995123,"eighty":267.473329,"marketCap":9943795914},{"date":"2022-08-12","current":828.064055,"twenty":-50.518997,"median":27.355854,"eighty":332.018448,"marketCap":10102381477},{"date":"2022-08-19","current":838.803881,"twenty":-50.518997,"median":43.704114,"eighty":339.430085,"marketCap":10233407347},{"date":"2022-08-26","current":822.106196,"twenty":-50.518997,"median":44.350706,"eighty":343.175456,"marketCap":10029695593},{"date":"2022-09-02","current":807.525119,"twenty":-50.518997,"median":44.8698,"eighty":348.23866,"marketCap":9851806456},{"date":"2022-09-09","current":834.962629,"twenty":-50.518997,"median":45.079259,"eighty":349.917301,"marketCap":10186544079},{"date":"2022-09-16","current":831.670128,"twenty":-50.518997,"median":45.502731,"eighty":362.813526,"marketCap":10146375564},{"date":"2022-09-23","current":811.366371,"twenty":-50.518997,"median":45.962631,"eighty":364.154541,"marketCap":9898669723},{"date":"2022-09-30","current":832.610843,"twenty":-50.518997,"median":46.285926,"eighty":365.308101,"marketCap":10157852283},{"date":"2022-10-07","current":848.602992,"twenty":-50.518997,"median":47.210279,"eighty":371.273896,"marketCap":10352956498},{"date":"2022-10-14","current":848.446206,"twenty":-50.518997,"median":49.327638,"eighty":378.797857,"marketCap":10351043711},{"date":"2022-10-21","current":869.690678,"twenty":-50.518997,"median":50.903135,"eighty":389.463975,"marketCap":10610226271},{"date":"2022-10-28","current":905.986584,"twenty":-50.518997,"median":51.513299,"eighty":431.928138,"marketCap":11053036327},{"date":"2022-11-04","current":201.221497,"twenty":-50.458475,"median":52.087035,"eighty":434.881702,"marketCap":11711091146},{"date":"2022-11-11","current":200.593816,"twenty":-50.126307,"median":52.792822,"eighty":434.881702,"marketCap":11674560078},{"date":"2022-11-18","current":198.47952,"twenty":-49.947556,"median":54.395533,"eighty":434.881702,"marketCap":11551508062},{"date":"2022-11-25","current":201.766589,"twenty":-49.629464,"median":57.560591,"eighty":434.881702,"marketCap":11742815494},{"date":"2022-12-02","current":209.463947,"twenty":-49.385812,"median":59.991394,"eighty":434.881702,"marketCap":12190801742},{"date":"2022-12-09","current":193.656283,"twenty":-48.929381,"median":62.264354,"eighty":434.881702,"marketCap":11270795649},{"date":"2022-12-16","current":193.573693,"twenty":-48.286719,"median":62.627396,"eighty":434.881702,"marketCap":11265988929},{"date":"2022-12-23","current":198.727289,"twenty":-40.846451,"median":63.253512,"eighty":434.881702,"marketCap":11565928220},{"date":"2022-12-30","current":197.290229,"twenty":-39.648276,"median":63.753352,"eighty":434.881702,"marketCap":11482291302},{"date":"2023-01-06","current":203.20365,"twenty":-39.648276,"median":64.910878,"eighty":434.881702,"marketCap":11826452411},{"date":"2023-01-13","current":180.028985,"twenty":-39.648276,"median":65.66327,"eighty":434.881702,"marketCap":10477686948},{"date":"2023-01-20","current":183.943736,"twenty":-39.648276,"median":66.031573,"eighty":434.881702,"marketCap":10705525447},{"date":"2023-01-27","current":178.806658,"twenty":-37.833689,"median":67.168053,"eighty":434.881702,"marketCap":10406547501},{"date":"2023-02-03","current":181.746851,"twenty":-35.951624,"median":67.783646,"eighty":434.881702,"marketCap":10577666711},{"date":"2023-02-10","current":64.510722,"twenty":15.966099,"median":67.783646,"eighty":434.881702,"marketCap":9966906536},{"date":"2023-02-17","current":64.729529,"twenty":16.188336,"median":67.783646,"eighty":434.881702,"marketCap":10000712304},{"date":"2023-02-24","current":64.0481,"twenty":16.573519,"median":67.783646,"eighty":434.881702,"marketCap":9895431481},{"date":"2023-03-03","current":63.254141,"twenty":16.938226,"median":67.783646,"eighty":434.881702,"marketCap":9772764834},{"date":"2023-03-10","current":59.897008,"twenty":17.137429,"median":67.783646,"eighty":434.881702,"marketCap":9254087752},{"date":"2023-03-17","current":58.921752,"twenty":17.302081,"median":67.783646,"eighty":434.881702,"marketCap":9103410611},{"date":"2023-03-24","current":60.672212,"twenty":17.624986,"median":67.783646,"eighty":434.881702,"marketCap":9373856762},{"date":"2023-03-31","current":63.279148,"twenty":17.970498,"median":67.68894,"eighty":434.086512,"marketCap":9776628351},{"date":"2023-04-06","current":63.898061,"twenty":18.054957,"median":67.68894,"eighty":434.086512,"marketCap":9872250383},{"date":"2023-04-14","current":64.873317,"twenty":18.158185,"median":67.783646,"eighty":434.881702,"marketCap":10022927524},{"date":"2023-04-21","current":65.367197,"twenty":18.484076,"median":67.783646,"eighty":434.881702,"marketCap":10099231974},{"date":"2023-04-28","current":63.70426,"twenty":18.731906,"median":67.783646,"eighty":434.881702,"marketCap":9842308130},{"date":"2023-05-05","current":146.11832,"twenty":19.078272,"median":68.588653,"eighty":434.881702,"marketCap":9351572473},{"date":"2023-05-12","current":149.137041,"twenty":19.909208,"median":69.22003,"eighty":434.881702,"marketCap":9544770653},{"date":"2023-05-19","current":144.639451,"twenty":20.507993,"median":87.443915,"eighty":434.881702,"marketCap":9256924881},{"date":"2023-05-26","current":140.538259,"twenty":21.155662,"median":90.238157,"eighty":434.881702,"marketCap":8994448566},{"date":"2023-06-02","current":139.028898,"twenty":21.398536,"median":90.937629,"eighty":434.881702,"marketCap":8897849477},{"date":"2023-06-09","current":143.358782,"twenty":21.506213,"median":91.668604,"eighty":434.881702,"marketCap":9174962017},{"date":"2023-06-16","current":147.658173,"twenty":21.60402,"median":92.617131,"eighty":434.881702,"marketCap":9450123060},{"date":"2023-06-23","current":149.18278,"twenty":21.770569,"median":93.488972,"eighty":435.676893,"marketCap":9547697898},{"date":"2023-06-30","current":144.060101,"twenty":21.895923,"median":94.02934,"eighty":436.472083,"marketCap":9219846442},{"date":"2023-07-07","current":143.922886,"twenty":21.989585,"median":94.91316,"eighty":436.472083,"marketCap":9211064707},{"date":"2023-07-14","current":146.407995,"twenty":22.061764,"median":95.529687,"eighty":436.472083,"marketCap":9370111693},{"date":"2023-07-21","current":149.274256,"twenty":22.130933,"median":95.839905,"eighty":436.472083,"marketCap":9553552388},{"date":"2023-07-28","current":154.366443,"twenty":22.209371,"median":96.635182,"eighty":436.472083,"marketCap":9879452347},{"date":"2023-08-04","current":57.179827,"twenty":22.369622,"median":96.794628,"eighty":436.472083,"marketCap":10086521560},{"date":"2023-08-11","current":57.938239,"twenty":22.419379,"median":96.794628,"eighty":436.472083,"marketCap":10220305417},{"date":"2023-08-18","current":57.738949,"twenty":22.500257,"median":96.794628,"eighty":436.472083,"marketCap":10185150535},{"date":"2023-08-25","current":59.27238,"twenty":22.577261,"median":96.794628,"eighty":436.472083,"marketCap":10455647821},{"date":"2023-09-01","current":60.279905,"twenty":22.655218,"median":96.794628,"eighty":436.472083,"marketCap":10633375280},{"date":"2023-09-08","current":60.052935,"twenty":22.776647,"median":96.794628,"eighty":436.472083,"marketCap":10593337776},{"date":"2023-09-15","current":62.986937,"twenty":22.862726,"median":96.982474,"eighty":437.267273,"marketCap":11110895761},{"date":"2023-09-22","current":62.616035,"twenty":22.973265,"median":96.982474,"eighty":437.267273,"marketCap":11045468619},{"date":"2023-09-29","current":63.750885,"twenty":23.123786,"median":96.982474,"eighty":437.267273,"marketCap":11245656142},{"date":"2023-10-06","current":63.828387,"twenty":23.187287,"median":96.982474,"eighty":437.267273,"marketCap":11259327485},{"date":"2023-10-13","current":61.580831,"twenty":23.281362,"median":96.982474,"eighty":437.267273,"marketCap":10862858538},{"date":"2023-10-20","current":61.519936,"twenty":23.429531,"median":96.982474,"eighty":437.267273,"marketCap":10852116768},{"date":"2023-10-27","current":59.742927,"twenty":23.646846,"median":97.20033,"eighty":438.237231,"marketCap":10538652404},{"date":"2023-11-03","current":58.32872,"twenty":23.985048,"median":97.20033,"eighty":438.237231,"marketCap":11140785548},{"date":"2023-11-10","current":57.690854,"twenty":23.985048,"median":95.96752,"eighty":392.709437,"marketCap":11018953164},{"date":"2023-11-17","current":55.952155,"twenty":23.985048,"median":95.589827,"eighty":383.351833,"marketCap":10686861664},{"date":"2023-11-24","current":57.701142,"twenty":23.985048,"median":95.489796,"eighty":377.211039,"marketCap":11020918202},{"date":"2023-12-01","current":59.974826,"twenty":23.985048,"median":94.859599,"eighty":367.477481,"marketCap":11455191702},{"date":"2023-12-08","current":61.728957,"twenty":24.007626,"median":93.696554,"eighty":365.084276,"marketCap":11790230760},{"date":"2023-12-15","current":62.423408,"twenty":24.007626,"median":93.180509,"eighty":363.965151,"marketCap":11922870856},{"date":"2023-12-22","current":62.32567,"twenty":24.007626,"median":91.967766,"eighty":361.900364,"marketCap":11904202990},{"date":"2023-12-29","current":67.979014,"twenty":23.985048,"median":91.60565,"eighty":350.289361,"marketCap":12983991624},{"date":"2024-01-05","current":68.714617,"twenty":23.96247,"median":91.018028,"eighty":348.300433,"marketCap":13124491874},{"date":"2024-01-12","current":67.171393,"twenty":23.96247,"median":90.125498,"eighty":344.013234,"marketCap":12829736105},{"date":"2024-01-19","current":70.34529,"twenty":23.939892,"median":87.443915,"eighty":339.611278,"marketCap":13435950470},{"date":"2024-01-26","current":72.536668,"twenty":23.96247,"median":71.993968,"eighty":332.715749,"marketCap":13854503662},{"date":"2024-02-02","current":73.277416,"twenty":23.96247,"median":71.906519,"eighty":313.773789,"marketCap":13995986431},{"date":"2024-02-09","current":52.891564,"twenty":23.96247,"median":70.886562,"eighty":261.06275,"marketCap":13207023489},{"date":"2024-02-16","current":53.400095,"twenty":23.96247,"median":69.696194,"eighty":257.160449,"marketCap":13334003660},{"date":"2024-02-23","current":53.149035,"twenty":23.96247,"median":68.840647,"eighty":255.027964,"marketCap":13271313941},{"date":"2024-03-01","current":51.965465,"twenty":23.985048,"median":68.588653,"eighty":248.779166,"marketCap":12975776696},{"date":"2024-03-08","current":53.930111,"twenty":23.985048,"median":68.148768,"eighty":244.412047,"marketCap":13466348621},{"date":"2024-03-15","current":55.456397,"twenty":23.985048,"median":67.762962,"eighty":240.453561,"marketCap":13847462308},{"date":"2024-03-22","current":57.281564,"twenty":23.985048,"median":67.173314,"eighty":238.312647,"marketCap":14303206612},{"date":"2024-03-28","current":54.926381,"twenty":23.985048,"median":66.336739,"eighty":235.829511,"marketCap":13715117346},{"date":"2024-04-05","current":54.838709,"twenty":23.96247,"median":65.960543,"eighty":230.641182,"marketCap":13693225698},{"date":"2024-04-12","current":54.753332,"twenty":23.96247,"median":65.52974,"eighty":224.225614,"marketCap":13671906957},{"date":"2024-04-19","current":53.387822,"twenty":23.96247,"median":65.224959,"eighty":214.926531,"marketCap":13330939072},{"date":"2024-04-26","current":55.490466,"twenty":23.985048,"median":65.016713,"eighty":211.299293,"marketCap":13855969266},{"date":"2024-05-03","current":38.063574,"twenty":24.176232,"median":64.926662,"eighty":209.711716,"marketCap":14072103451},{"date":"2024-05-10","current":38.017298,"twenty":24.502187,"median":64.926662,"eighty":209.711716,"marketCap":14054995122},{"date":"2024-05-17","current":38.629778,"twenty":24.632825,"median":64.926662,"eighty":209.711716,"marketCap":14281428883},{"date":"2024-05-24","current":38.248679,"twenty":24.716549,"median":64.926662,"eighty":209.711716,"marketCap":14140536765},{"date":"2024-05-31","current":37.200658,"twenty":24.820876,"median":64.926662,"eighty":209.711716,"marketCap":13753083441},{"date":"2024-06-07","current":36.223413,"twenty":24.997349,"median":64.926662,"eighty":209.711716,"marketCap":13391795796},{"date":"2024-06-14","current":37.091773,"twenty":25.132663,"median":64.971688,"eighty":209.794306,"marketCap":13712828551},{"date":"2024-06-21","current":36.495626,"twenty":25.611349,"median":65.016713,"eighty":209.876896,"marketCap":13492433023},{"date":"2024-06-28","current":36.560957,"twenty":26.148895,"median":65.029383,"eighty":211.299293,"marketCap":13516585958},{"date":"2024-07-05","current":37.628033,"twenty":26.322584,"median":65.029383,"eighty":211.299293,"marketCap":13911083888},{"date":"2024-07-12","current":39.879237,"twenty":26.601174,"median":65.029383,"eighty":211.299293,"marketCap":14743353755},{"date":"2024-07-15","current":40.131034,"twenty":26.615894,"median":65.029383,"eighty":211.299293,"marketCap":14836443190},{"date":"2024-08-02","current":45.591134,"twenty":26.86173,"median":65.123383,"eighty":209.546537,"marketCap":15464512534},{"date":"2024-08-09","current":43.679968,"twenty":26.86173,"median":64.926662,"eighty":203.758652,"marketCap":14816245015},{"date":"2024-08-16","current":43.989565,"twenty":26.86173,"median":64.824841,"eighty":201.969234,"marketCap":14921260314},{"date":"2024-08-23","current":45.418474,"twenty":26.86173,"median":64.529477,"eighty":201.100989,"marketCap":15405946309},{"date":"2024-08-30","current":38.232251,"twenty":26.86173,"median":64.341928,"eighty":199.724972,"marketCap":12968379659},{"date":"2024-09-06","current":36.082934,"twenty":26.86173,"median":64.216895,"eighty":198.7372,"marketCap":12239331141},{"date":"2024-09-13","current":36.103772,"twenty":26.86173,"median":63.998087,"eighty":198.373805,"marketCap":12246399478},{"date":"2024-09-20","current":35.859667,"twenty":26.86173,"median":63.828387,"eighty":196.979242,"marketCap":12163598954},{"date":"2024-09-27","current":34.511134,"twenty":26.86173,"median":63.679253,"eighty":196.20378,"marketCap":11706176546},{"date":"2024-10-04","current":33.305492,"twenty":26.86173,"median":63.327173,"eighty":193.88423,"marketCap":11297222738},{"date":"2024-10-11","current":33.463267,"twenty":26.86173,"median":63.274802,"eighty":189.672156,"marketCap":11350740150},{"date":"2024-10-18","current":35.264288,"twenty":26.86173,"median":63.195636,"eighty":182.652034,"marketCap":11961646456},{"date":"2024-10-25","current":34.389081,"twenty":26.86173,"median":62.986937,"eighty":181.026669,"marketCap":11664776284},{"date":"2024-10-31","current":32.619923,"twenty":26.86173,"median":62.892828,"eighty":179.513625,"marketCap":12588028444},{"date":"2024-11-08","current":32.528095,"twenty":26.852907,"median":62.621935,"eighty":178.558889,"marketCap":12552592025},{"date":"2024-11-15","current":32.238181,"twenty":26.852907,"median":62.553735,"eighty":154.18349,"marketCap":12440714189},{"date":"2024-11-22","current":32.795708,"twenty":26.852907,"median":62.388604,"eighty":149.95728,"marketCap":12655863875},{"date":"2024-11-29","current":33.254848,"twenty":26.852907,"median":62.257511,"eighty":149.213272,"marketCap":12833045969},{"date":"2024-12-06","current":33.168268,"twenty":26.852907,"median":61.886863,"eighty":148.618675,"marketCap":12799634488},{"date":"2024-12-13","current":33.265343,"twenty":26.852907,"median":61.550384,"eighty":147.743551,"marketCap":12837095845},{"date":"2024-12-20","current":35.40887,"twenty":26.852907,"median":61.259752,"eighty":146.444586,"marketCap":13664283108},{"date":"2024-12-27","current":36.476699,"twenty":26.852907,"median":61.063228,"eighty":145.764611,"marketCap":14076358036},{"date":"2025-01-03","current":36.169731,"twenty":26.852907,"median":60.907571,"eighty":144.785813,"marketCap":13957899150},{"date":"2025-01-10","current":36.392742,"twenty":26.844083,"median":60.680648,"eighty":144.044855,"marketCap":14043959024},{"date":"2025-01-17","current":37.234935,"twenty":26.844083,"median":60.329767,"eighty":143.386225,"marketCap":14368961609},{"date":"2025-01-24","current":38.719925,"twenty":26.844083,"median":60.247462,"eighty":142.678807,"marketCap":14942019125},{"date":"2025-01-31","current":40.218033,"twenty":26.844083,"median":59.974826,"eighty":141.016986,"marketCap":15520138987},{"date":"2025-02-07","current":44.648909,"twenty":26.844083,"median":59.754628,"eighty":137.028614,"marketCap":15238672574},{"date":"2025-02-14","current":34.141082,"twenty":26.844083,"median":59.521493,"eighty":131.55311,"marketCap":11652351200},{"date":"2025-02-21","current":33.919064,"twenty":26.844083,"median":59.27238,"eighty":130.444741,"marketCap":11576576519},{"date":"2025-02-28","current":34.328044,"twenty":26.844083,"median":59.040533,"eighty":129.095424,"marketCap":11716161457},{"date":"2025-03-07","current":32.91122,"twenty":26.83526,"median":58.73161,"eighty":127.751461,"marketCap":11232599351},{"date":"2025-03-14","current":31.839108,"twenty":26.83526,"median":58.3673,"eighty":127.30972,"marketCap":10866687407},{"date":"2025-03-21","current":32.154607,"twenty":26.83526,"median":57.889136,"eighty":126.142453,"marketCap":10974367216},{"date":"2025-03-28","current":33.302672,"twenty":26.83526,"median":57.695998,"eighty":125.695358,"marketCap":11366202078},{"date":"2025-04-04","current":30.054201,"twenty":26.83526,"median":57.273606,"eighty":124.678015,"marketCap":10257498857},{"date":"2025-04-11","current":26.501916,"twenty":26.750137,"median":56.720224,"eighty":122.876248,"marketCap":9045103969},{"date":"2025-04-17","current":29.242083,"twenty":26.695569,"median":56.384258,"eighty":119.27935,"marketCap":9980323052},{"date":"2025-04-25","current":30.658387,"twenty":26.680493,"median":56.257145,"eighty":115.693273,"marketCap":10463707627},{"date":"2025-05-02","current":30.898993,"twenty":26.680493,"median":56.044889,"eighty":114.003704,"marketCap":10545826362},{"date":"2025-05-09","current":38.032908,"twenty":26.680493,"median":55.948895,"eighty":113.591967,"marketCap":11630463166},{"date":"2025-05-16","current":38.922888,"twenty":26.680493,"median":55.567979,"eighty":113.591967,"marketCap":11902619171},{"date":"2025-05-23","current":38.550714,"twenty":26.680493,"median":55.400605,"eighty":113.591967,"marketCap":11788808478},{"date":"2025-05-30","current":40.019991,"twenty":26.680493,"median":55.045675,"eighty":113.591967,"marketCap":12238113301},{"date":"2025-06-06","current":40.327439,"twenty":26.680493,"median":54.834724,"eighty":113.591967,"marketCap":12332130830},{"date":"2025-06-13","current":40.456891,"twenty":26.680493,"median":54.478076,"eighty":113.591967,"marketCap":12371717158},{"date":"2025-06-20","current":41.201238,"twenty":26.665418,"median":53.930111,"eighty":113.621107,"marketCap":12599338544},{"date":"2025-06-27","current":41.00706,"twenty":26.665418,"median":53.569084,"eighty":113.621107,"marketCap":12539959052},{"date":"2025-07-03","current":41.783771,"twenty":26.665418,"median":53.336333,"eighty":113.621107,"marketCap":12777477020},{"date":"2025-07-11","current":43.664056,"twenty":26.665418,"median":53.065577,"eighty":113.621107,"marketCap":13352468434},{"date":"2025-07-18","current":43.401917,"twenty":26.665418,"median":52.829249,"eighty":113.621107,"marketCap":13272306120},{"date":"2025-07-25","current":42.602552,"twenty":26.665418,"median":52.511422,"eighty":113.621107,"marketCap":13027860544},{"date":"2025-08-01","current":36.514628,"twenty":26.665418,"median":52.087035,"eighty":113.621107,"marketCap":12718045027},{"date":"2025-08-08","current":35.765712,"twenty":26.665418,"median":51.986859,"eighty":113.621107,"marketCap":12457197656},{"date":"2025-08-15","current":37.391686,"twenty":26.665418,"median":51.677224,"eighty":113.621107,"marketCap":13023524078},{"date":"2025-08-22","current":38.522178,"twenty":26.665418,"median":50.766532,"eighty":113.621107,"marketCap":13417274672},{"date":"2025-08-29","current":39.564396,"twenty":26.665418,"median":49.022556,"eighty":113.621107,"marketCap":13780278999},{"date":"2025-09-05","current":39.980144,"twenty":26.660526,"median":47.055461,"eighty":113.639848,"marketCap":13925084004},{"date":"2025-09-12","current":40.891372,"twenty":26.665418,"median":46.381549,"eighty":113.621107,"marketCap":14242464836},{"date":"2025-09-19","current":41.477975,"twenty":26.665418,"median":46.003612,"eighty":113.621107,"marketCap":14446778746},{"date":"2025-09-26","current":40.119675,"twenty":26.665418,"median":46.003612,"eighty":113.621107,"marketCap":13973682943},{"date":"2025-10-03","current":38.937926,"twenty":26.665418,"median":46.003612,"eighty":113.621107,"marketCap":13562079677},{"date":"2025-10-10","current":39.430559,"twenty":26.665418,"median":45.680316,"eighty":113.621107,"marketCap":13733663689},{"date":"2025-10-17","current":39.160038,"twenty":26.665418,"median":45.489919,"eighty":113.621107,"marketCap":13639441255},{"date":"2025-10-24","current":40.911305,"twenty":26.665418,"median":45.418474,"eighty":113.621107,"marketCap":14249407541},{"date":"2025-10-31","current":32.157417,"twenty":26.665418,"median":45.329167,"eighty":113.621107,"marketCap":13763374551},{"date":"2025-11-07","current":36.06178,"twenty":26.665418,"median":44.861795,"eighty":113.621107,"marketCap":15434442050},{"date":"2025-11-14","current":33.58428,"twenty":26.665418,"median":43.968726,"eighty":113.621107,"marketCap":14374071952},{"date":"2025-11-21","current":32.376397,"twenty":26.665418,"median":43.66806,"eighty":113.621107,"marketCap":13857097908},{"date":"2025-11-28","current":35.446773,"twenty":26.665418,"median":43.352509,"eighty":113.621107,"marketCap":15171219007},{"date":"2025-12-05","current":35.926665,"twenty":26.665418,"median":43.191558,"eighty":113.621107,"marketCap":15376612745},{"date":"2025-12-12","current":36.050133,"twenty":26.665418,"median":42.725532,"eighty":113.621107,"marketCap":15429456765},{"date":"2025-12-19","current":33.042655,"twenty":26.665418,"median":41.783771,"eighty":113.621107,"marketCap":14142256204},{"date":"2025-12-26","current":34.228407,"twenty":26.665418,"median":41.688697,"eighty":113.621107,"marketCap":14649758207},{"date":"2026-01-02","current":33.040325,"twenty":26.665418,"median":41.424542,"eighty":113.621107,"marketCap":14141259147},{"date":"2026-01-09","current":31.582013,"twenty":26.665418,"median":41.053684,"eighty":113.621107,"marketCap":13517101477},{"date":"2026-01-16","current":31.064848,"twenty":26.665418,"median":40.948324,"eighty":113.621107,"marketCap":13295754828},{"date":"2026-01-23","current":32.001336,"twenty":26.665418,"median":40.689904,"eighty":113.246297,"marketCap":13696571734},{"date":"2026-01-30","current":32.138781,"twenty":26.665418,"median":40.57987,"eighty":112.603765,"marketCap":13755398096},{"date":"2026-02-06","current":32.131792,"twenty":26.764151,"median":40.453654,"eighty":110.060408,"marketCap":13752406925},{"date":"2026-02-13","current":25.645156,"twenty":26.870554,"median":40.453654,"eighty":110.060408,"marketCap":12273771423},{"date":"2026-02-20","current":27.282254,"twenty":26.921566,"median":40.453654,"eighty":110.060408,"marketCap":13057286536},{"date":"2026-02-27","current":27.395493,"twenty":26.995123,"median":40.453654,"eighty":110.060408,"marketCap":13111482806},{"date":"2026-03-06","current":27.185791,"twenty":27.241002,"median":40.453654,"eighty":110.060408,"marketCap":13011119343},{"date":"2026-03-13","current":26.795744,"twenty":27.246604,"median":40.453654,"eighty":110.060408,"marketCap":12824443302},{"date":"2026-03-20","current":27.198373,"twenty":27.355854,"median":40.453654,"eighty":110.060408,"marketCap":13017141151},{"date":"2026-03-27","current":27.768763,"twenty":27.410172,"median":40.453654,"eighty":110.060408,"marketCap":13290129770},{"date":"2026-04-02","current":27.798121,"twenty":27.462597,"median":40.453654,"eighty":110.060408,"marketCap":13304180655},{"date":"2026-04-10","current":27.605195,"twenty":27.596807,"median":40.453654,"eighty":110.060408,"marketCap":13211846269},{"date":"2026-04-17","current":26.927857,"twenty":27.596807,"median":40.453654,"eighty":110.060408,"marketCap":12887672283},{"date":"2026-04-24","current":27.360571,"twenty":27.626165,"median":40.453654,"eighty":110.060408,"marketCap":13094769408},{"date":"2026-05-01","current":27.671606,"twenty":27.654794,"median":40.453654,"eighty":110.060408,"marketCap":13243630754},{"date":"2026-05-08","current":22.496668,"twenty":27.694724,"median":40.453654,"eighty":110.060408,"marketCap":15041271956},{"date":"2026-05-15","current":23.919346,"twenty":27.694724,"median":40.453654,"eighty":110.060408,"marketCap":15992474796},{"date":"2026-05-22","current":23.385466,"twenty":27.694724,"median":40.453654,"eighty":110.060408,"marketCap":15635522356},{"date":"2026-05-29","current":23.519312,"twenty":27.715019,"median":40.453654,"eighty":110.223718,"marketCap":15725011841},{"date":"2026-06-05","current":25.167574,"twenty":27.694724,"median":40.453654,"eighty":110.060408,"marketCap":16827039655},{"date":"2026-06-12","current":24.469769,"twenty":27.694724,"median":40.453654,"eighty":110.060408,"marketCap":16360487733},{"date":"2026-06-18","current":23.911827,"twenty":27.694724,"median":40.453654,"eighty":110.060408,"marketCap":15987447297},{"date":"2026-06-26","current":24.690841,"twenty":27.715019,"median":40.453654,"eighty":110.223718,"marketCap":16508296208},{"date":"2026-07-02","current":25.230737,"twenty":27.715019,"median":40.453654,"eighty":110.223718,"marketCap":16869270647},{"date":"2026-07-10","current":27.152706,"twenty":27.715019,"median":40.453654,"eighty":110.223718,"marketCap":18154299430},{"date":"2026-07-17","current":25.799207,"twenty":27.715019,"median":40.453654,"eighty":110.223718,"marketCap":17249349583},{"date":"2026-07-24","current":26.190218,"twenty":27.715019,"median":40.453654,"eighty":110.223718,"marketCap":17510779539},{"date":"2026-07-31","current":26.438018,"twenty":27.727905,"median":40.453654,"eighty":110.387029,"marketCap":18652021846},{"date":"2026-08-07","current":23.027033,"twenty":27.727905,"median":40.453654,"eighty":110.387029,"marketCap":16245572107},{"date":"2026-08-14","current":21.730304,"twenty":27.727905,"median":40.453654,"eighty":110.387029,"marketCap":15330729478},{"date":"2026-08-21","current":22.034315,"twenty":27.727905,"median":40.453654,"eighty":110.387029,"marketCap":15545209250},{"date":"2026-08-28","current":22.465117,"twenty":27.727905,"median":40.453654,"eighty":110.387029,"marketCap":15849140301},{"date":"2026-09-04","current":22.815234,"twenty":27.727905,"median":40.453654,"eighty":110.387029,"marketCap":16096147811},{"date":"2026-09-10","current":22.352734,"twenty":27.727905,"median":40.453654,"eighty":110.387029,"marketCap":15769853940}],"updateTime":1789165873934},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NBIX\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1182457826","title":"Stock Track | Neurocrine Biosciences Soars 8.85% After-Hours on Strong Q1 Earnings Beat and $2.9B Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=1182457826","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182457826?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:33","pubTimestamp":1778013234,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences' stock surged 8.85% in after-hours trading on Tuesday, following the release of its first-quarter 2026 financial results.The biopharmaceutical company reported adjusted...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["NBIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633929332","title":"Neurocrine Biosciences Q1 adjusted EPS beats estimates, sales up 44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633929332","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633929332?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:15","pubTimestamp":1778012139,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences Q1 adjusted EPS beats estimates, sales up 44%OverviewU.S. biopharma firm's Q1 net product sales rose 44% yr/yr, driven by INGREZZA and CRENESSITYAdjusted EPS and adjusted net in","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nL1N41I19X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171402.SGD","LU0889565916.HKD","LU0109394709.USD","BK4139","LU2324357040.USD","LU2065170008.USD","SLNO","LU0320765992.SGD","LU2065171311.SGD","NBIX","LU0154245756.USD","LU0154245673.USD","LU0823416689.USD","LU2065169927.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633929789","title":"Neurocrine reports Q1 adjusted EPS $1.94, consensus $1.70","url":"https://stock-news.laohu8.com/highlight/detail?id=2633929789","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633929789?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:11","pubTimestamp":1778011904,"startTime":"0","endTime":"0","summary":"Reports Q1 revenue $811M, consensus $767.88M. “Neurocrine’s (NBIX) strong first-quarter performance reflects continued momentum across our commerci...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurocrine-reports-q1-adjusted-eps-1-94-consensus-1-70-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurocrine-reports-q1-adjusted-eps-1-94-consensus-1-70-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","LU0320765992.SGD","LU2065169927.USD","LU2065171402.SGD","LU2065171311.SGD","LU0154245673.USD","NBIX","LU0823416689.USD","BK4139","LU2065170008.USD","LU2324357040.USD","LU0109394709.USD","LU0154245756.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633792940","title":"Neurocrine backs FY26 Ingrezza net product sales $2.7B-$2.8B","url":"https://stock-news.laohu8.com/highlight/detail?id=2633792940","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633792940?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:10","pubTimestamp":1778011819,"startTime":"0","endTime":"0","summary":"16:02 EDT Neurocrine (NBIX) backs FY26 Ingrezza net product sales $2.7B-$2.8B Published first on TheFly – the ultimate source for real-time, market...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurocrine-backs-fy26-ingrezza-net-product-sales-2-7b-2-8b-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurocrine-backs-fy26-ingrezza-net-product-sales-2-7b-2-8b-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0154245673.USD","LU2065170008.USD","LU2065171311.SGD","LU0320765992.SGD","BK4139","LU0823416689.USD","LU0154245756.USD","LU2324357040.USD","NBIX","LU0109394709.USD","LU0889565916.HKD","LU2065169927.USD","LU2065171402.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633925153","title":"Neurocrine Q1 FY26 net income rises to $197.9 million; net product sales climb 44% to $811 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633925153","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633925153?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:02","pubTimestamp":1778011323,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences posted first-quarter results with net product sales rising 44% year over year to USD 811 million.GAAP net income came in at USD 197.9 million, lifting diluted EPS to USD 1.91.INGREZZA net product sales climbed 20% year over year to USD 656.9 million, while CRENESSITY net product sales reached USD 153.3 million.Announced definitive agreement to acquire Soleno Therapeutics for USD 53 per share in cash, valuing deal at USD 2.9 billion, expected to close in Q2 2026.Reaffirmed full-year 2026 INGREZZA net sales guidance of USD 2.7 billion to USD 2.8 billion.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDL5CClpJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","LU2065171402.SGD","LU2324357040.USD","LU2065170008.USD","NBIX","LU0154245673.USD","LU2065169927.USD","LU0320765992.SGD","LU0154245756.USD","LU2065171311.SGD","LU0889565916.HKD","SLNO","LU0109394709.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633925678","title":"BRIEF-Neurocrine Biosciences Q1 Adjusted EPS USD 1.94 Vs. IBES Estimate USD 1.15","url":"https://stock-news.laohu8.com/highlight/detail?id=2633925678","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633925678?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:01","pubTimestamp":1778011306,"startTime":"0","endTime":"0","summary":"BRIEF-Neurocrine Biosciences Q1 Adjusted EPS USD 1.94 Vs. IBES Estimate USD 1.15\n\n\nMay 05 (Reuters) - Neurocrine Biosciences Q1 EPS USD 1.91.\n\nQ1 net income USD 197.9 million\nQ1 adjusted net income USD 200.5 million vs. IBES estimate USD 131.4 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nPLX5B2565:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU2065170008.USD","LU2065171402.SGD","LU2324357040.USD","NBIX","LU0154245673.USD","LU0320765992.SGD","LU0823416689.USD","LU2065169927.USD","LU2065171311.SGD","BK4139","LU0109394709.USD","LU0154245756.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633925911","title":"Neurocrine Biosciences Q1 Net Income USD 197.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633925911","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633925911?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:01","pubTimestamp":1778011261,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nPLX5B2565:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2065169927.USD","LU2065171311.SGD","LU0889565916.HKD","LU0320765992.SGD","LU0109394709.USD","LU0154245673.USD","LU0823416689.USD","LU0154245756.USD","LU2324357040.USD","NBIX","LU2065170008.USD","BK4139","LU2065171402.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633925103","title":"Neurocrine Biosciences Inc - Reaffirms 2026 Full-Year Ingrezza Net Sales Guidance $2.7-$2.8 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2633925103","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633925103?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:01","pubTimestamp":1778011261,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nPLX5B2565:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2065171402.SGD","LU0889565916.HKD","NBIX","LU0823416689.USD","LU2065169927.USD","LU0320765992.SGD","LU0154245673.USD","LU0154245756.USD","LU2065170008.USD","LU2065171311.SGD","BK4139","LU2324357040.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633994370","title":"Neurocrine Biosciences executives to present at Bank of America Health Care Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2633994370","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633994370?lang=en_us&edition=fundamental","pubTime":"2026-05-05 21:02","pubTimestamp":1777986176,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences executives scheduled to present at Bank of America Health Care Conference on May 12, 2026 in Las Vegas.Presentation set for 11:20 a.m. PT, 2:20 p.m. ET.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurocrine Biosciences Inc. published the original content used to generate this news brief via PR Newswire  on May 05, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDL4ZxtC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BAC","LU0648001328.SGD","BK4207","LU1883839398.USD","LU0321505868.SGD","LU0130517989.USD","LU2129689431.USD","LU1069347547.HKD","IE00BFXG1179.USD","IE00B1BXHZ80.USD","IE0034235188.USD","LU0320765646.SGD","LU0098860793.USD","LU0971096721.USD","LU1201861165.SGD","LU1804176565.USD","BK4559","LU2065169927.USD","LU0640476718.USD","LU0053666078.USD","LU0208291251.USD","NBIX","LU1718418525.SGD","LU1496350502.SGD","BK4553","LU2265009873.SGD","LU1363072403.SGD","LU0310800965.SGD","LU0170899867.USD","IE00BLSP4239.USD","LU0234572021.USD","LU0683600562.USD","LU1496350171.SGD","IE00B7SZLL34.SGD","LU0477156953.USD","LU2065171311.SGD","LU0106831901.USD","LU0314106906.USD","LU0203347892.USD","LU2065171402.SGD","IE00BBT3K403.USD","LU2324357040.USD","IE00BKVL7J92.USD","LU0306806265.USD","LU0234570918.USD","LU1366192091.USD","LU0211331839.USD","LU1894683348.USD","LU0256863902.USD","LU1074936037.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632295313","title":"BRIEF-Neurocrine Biosciences Announces New Survey Results Showing Significant Burden Of Tardive Dyskinesia On Employment","url":"https://stock-news.laohu8.com/highlight/detail?id=2632295313","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632295313?lang=en_us&edition=fundamental","pubTime":"2026-05-04 20:34","pubTimestamp":1777898089,"startTime":"0","endTime":"0","summary":"BRIEF-Neurocrine Biosciences Announces New Survey Results Showing Significant Burden Of Tardive Dyskinesia On EmploymentMay 4 (Reuters) - Neurocrine Biosciences Inc NBIX.O:NEUROCRINE BIOSCIENCES ANNOU","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nFWN41H07I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBIX","LU0109394709.USD","LU2065171311.SGD","LU2065170008.USD","LU0823416689.USD","LU0889565916.HKD","BK4139","LU0154245673.USD","LU2065169927.USD","LU0154245756.USD","LU2065171402.SGD","LU2324357040.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632953989","title":"Neurocrine Biosciences Announces New Survey Results Showing Significant Burden of Tardive Dyskinesia on Employment","url":"https://stock-news.laohu8.com/highlight/detail?id=2632953989","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632953989?lang=en_us&edition=fundamental","pubTime":"2026-05-04 20:31","pubTimestamp":1777897871,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nFWN41H07I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2065169927.USD","LU0823416689.USD","LU2065170008.USD","BK4139","LU0154245756.USD","LU2065171402.SGD","LU2065171311.SGD","LU0320765992.SGD","NBIX","LU2324357040.USD","LU0109394709.USD","LU0154245673.USD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632958376","title":"Neurocrine Biosciences Announces Initiation Of Phase 1 Clinical Study Evaluating Nbip-'2118, A Corticotropin-Releasing Factor Type 2 Receptor Agonist","url":"https://stock-news.laohu8.com/highlight/detail?id=2632958376","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632958376?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:51","pubTimestamp":1777895493,"startTime":"0","endTime":"0","summary":"May 4 (Reuters) - Neurocrine Biosciences Inc ::*NEUROCRINE BIOSCIENCES ANNOUNCES INITIATION OF PHASE 1 CLINICAL STUDY EVALUATING NBIP-'2118, A CORTICOTROPIN-RELEASING FACTOR TYPE 2 RECEPTOR AGONIST*NE","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nRSD3W57R6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0154245673.USD","BK4139","LU2324357040.USD","LU2065169927.USD","LU2065171311.SGD","LU2065170008.USD","LU0154245756.USD","LU0823416689.USD","LU0320765992.SGD","LU0889565916.HKD","LU2065171402.SGD","NBIX","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632740930","title":"Neurocrine initiates Phase 1 study of NBIP-‘2118","url":"https://stock-news.laohu8.com/highlight/detail?id=2632740930","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632740930?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:40","pubTimestamp":1777894816,"startTime":"0","endTime":"0","summary":"Neurocrine (NBIX) Biosciences announced the initiation of a Phase 1 first-in-human clinical study evaluating the safety and tolerability of NBIP-‘2...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurocrine-initiates-phase-1-study-of-nbip-2118-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurocrine-initiates-phase-1-study-of-nbip-2118-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","LU0154245756.USD","LU2324357040.USD","NBIX","LU2065171311.SGD","LU2065171402.SGD","LU2065169927.USD","LU0320765992.SGD","LU0823416689.USD","LU2065170008.USD","BK4139","LU0154245673.USD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632930140","title":"Neurocrine initiates Phase 1 trial of obesity drug candidate NBIP-2118","url":"https://stock-news.laohu8.com/highlight/detail?id=2632930140","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632930140?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:32","pubTimestamp":1777894341,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences initiated Phase 1 first-in-human trial for NBIP-'2118, investigational once-weekly injectable obesity drug designed to drive weight loss while preserving lean mass.Study will test safety and tolerability across single ascending doses versus placebo in healthy-weight adults plus participants who are overweight or obese.No clinical results have been presented; initial data expected in 2027.Program positions CRF2 agonism as potential standalone option or combination partner with incretin-based approaches, supporting broader obesity pipeline strategy.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nNDL14dbQ9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU2065169927.USD","LU0823416689.USD","LU2065171402.SGD","LU0109394709.USD","NBIX","LU2324357040.USD","LU0889565916.HKD","LU2065171311.SGD","LU0320765992.SGD","LU0154245756.USD","LU0154245673.USD","LU2065170008.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632930944","title":"Neurocrine Biosciences Inc - Initial Data From Phase 1 Nbip-'2118 Study Expected in 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2632930944","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632930944?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:30","pubTimestamp":1777894205,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nTUA7TJB47:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2324357040.USD","BK4139","LU0823416689.USD","LU2065169927.USD","NBIX","LU2065171311.SGD","LU0154245673.USD","LU2065171402.SGD","LU0889565916.HKD","LU0109394709.USD","LU2065170008.USD","LU0154245756.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632647937","title":"Neurocrine presents two-year Crenessity data","url":"https://stock-news.laohu8.com/highlight/detail?id=2632647937","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632647937?lang=en_us&edition=fundamental","pubTime":"2026-05-02 04:11","pubTimestamp":1777666302,"startTime":"0","endTime":"0","summary":"Neurocrine (NBIX) Biosciences announced the presentation of new two-year data from the Phase 3 CAHtalyst Pediatric study demonstrating durable andr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurocrine-presents-two-year-crenessity-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurocrine-presents-two-year-crenessity-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065169927.USD","LU0823416689.USD","LU0320765992.SGD","LU0889565916.HKD","LU0109394709.USD","LU0154245673.USD","LU2065171402.SGD","LU2065170008.USD","LU0154245756.USD","LU2065171311.SGD","NBIX","LU2324357040.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632642706","title":"Neurocrine says Phase 3 pediatric CAH trial shows durable hormone control at two years","url":"https://stock-news.laohu8.com/highlight/detail?id=2632642706","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632642706?lang=en_us&edition=fundamental","pubTime":"2026-05-02 04:06","pubTimestamp":1777665993,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences presented new two-year Phase 3 CAHtalyst Pediatric data for CRENESSITY  at Pediatric Endocrine Society 2026 Annual Meeting.Results showed sustained hormone control in children and adolescents with classic congenital adrenal hyperplasia while supporting lower, more physiologic glucocorticoid use.Clinical readouts pointed to improvements in cardiometabolic risk markers, including weight-related measures and insulin resistance, in patients who entered study with those issues.Data also indicated improvement in select signs linked to excess androgens, supporting broader symptom control over time.Neurocrine flagged plans to present additional two-year endpoint data at upcoming medical meetings, with no new safety signals reported in follow-up.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nNDL6HVX7T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","LU2065171311.SGD","LU2065169927.USD","LU0154245756.USD","LU2065170008.USD","LU0823416689.USD","BK4139","LU0320765992.SGD","LU0154245673.USD","LU2065171402.SGD","NBIX","LU0889565916.HKD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632790642","title":"Neurocrine Biosciences Presents New Two-Year Crenessity® (Crinecerfont) Data Demonstrating Durable Hormone Control, Reduced Glucocorticoid Exposure and Meaningful Clinical Improvements in Pediatric Patients With Classic Congenital Adrenal Hyperplasia","url":"https://stock-news.laohu8.com/highlight/detail?id=2632790642","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632790642?lang=en_us&edition=fundamental","pubTime":"2026-05-02 04:05","pubTimestamp":1777665900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nTUA7WGRPS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0154245756.USD","LU2065171311.SGD","LU0823416689.USD","LU2065169927.USD","LU0109394709.USD","BK4139","LU0889565916.HKD","NBIX","LU2065171402.SGD","LU2324357040.USD","LU0320765992.SGD","LU0154245673.USD","LU2065170008.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142171120","title":"Earning Preview: Neurocrine Biosciences revenue expected to increase by 37.63%, institutions are bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1142171120","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142171120?lang=en_us&edition=fundamental","pubTime":"2026-04-28 19:01","pubTimestamp":1777374098,"startTime":"0","endTime":"0","summary":"Abstract Neurocrine Biosciences will report its fiscal first-quarter 2026 results on May 5, 2026 Post Market; this preview synthesizes current-quarter revenue and EPS expectations, last quarter’s...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Earning Preview: Neurocrine Biosciences revenue expected to increase by 37.63%, institutions are bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630354122","title":"A Look At Neurocrine Biosciences (NBIX) Valuation After CRENESSITY Phase 3 CAHtalyst Adult Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2630354122","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630354122?lang=en_us&edition=fundamental","pubTime":"2026-04-27 11:11","pubTimestamp":1777259465,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences (NBIX) is back in focus after new two year Phase 3 CAHtalyst Adult data for CRENESSITY in classic congenital adrenal hyperplasia, highlighting sustained glucocorticoid reductions and a clean safety profile.\nSee our latest analysis for Neurocrine Biosciences.\nAt a share price of $127.68, Neurocrine Biosciences has seen a 1 year total shareholder return of 19.63%, while its year to date share price return of 9.19% points to fading short term momentum following recent...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nbix/neurocrine-biosciences/news/a-look-at-neurocrine-biosciences-nbix-valuation-after-crenes","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nbix/neurocrine-biosciences/news/a-look-at-neurocrine-biosciences-nbix-valuation-after-crenes","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2065170008.USD","LU2065171311.SGD","BK4139","NBIX","LU2324357040.USD","LU0109394709.USD","LU0154245756.USD","LU0154245673.USD","LU2065171402.SGD","LU0823416689.USD","LU0889565916.HKD","LU2065169927.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":199,"code":"91000000","status":"200"}]}}